Nuclear medicine : : Radioactivity for diagnosis and therapy / / Richard Zimmermann.

Nuclear medicine is a growing specialized medical field in which radiopharmaceuticals, i.e. drugs associated to radioactivity, are used for diagnostic or therapeutic purposes. Since 1942, nuclear medicine has progressed in such a way that it became a major diagnostic tool in hospitals. The past ten...

Full description

Saved in:
Bibliographic Details
Superior document:Title is part of eBook package: De Gruyter EDP Sciences Contemporary eBook-Package 2016-2020
VerfasserIn:
Place / Publishing House:Les Ulis : : EDP Sciences, , [2021]
©2017
Year of Publication:2021
Language:English
Online Access:
Physical Description:1 online resource (216 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 05201nam a22007095i 4500
001 9782759821495
003 DE-B1597
005 20221201113901.0
006 m|||||o||d||||||||
007 cr || ||||||||
008 221201t20212017fr fo d z eng d
020 |a 9782759821495 
024 7 |a 10.1051/978-2-7598-2149-5  |2 doi 
035 |a (DE-B1597)573269 
040 |a DE-B1597  |b eng  |c DE-B1597  |e rda 
041 0 |a eng 
044 |a fr  |c FR 
050 4 |a R895 
072 7 |a MED003040  |2 bisacsh 
082 0 4 |a 616.07575 
100 1 |a Zimmermann, Richard,   |e author.  |4 aut  |4 http://id.loc.gov/vocabulary/relators/aut 
245 1 0 |a Nuclear medicine :  |b Radioactivity for diagnosis and therapy /  |c Richard Zimmermann. 
264 1 |a Les Ulis :   |b EDP Sciences,   |c [2021] 
264 4 |c ©2017 
300 |a 1 online resource (216 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
505 0 0 |t Frontmatter --   |t Dedication --   |t CONTENTS --   |t Preface --   |t Introduction and Definitions --   |t 1. Nuclear Medicine, What For? --   |t 2. A Little History... --   |t 3. Some Basic Notions of Radiation --   |t 4. SPECT Imaging: Gamma Ray Imaging --   |t 5. PET Imaging: Positron Emission Tomography --   |t 6. Therapeutic Applications --   |t 7. The Development of Radiopharmaceuticals --   |t 8. The Production of Radiopharmaceuticals --   |t 9. The Future of Nuclear Medicine --   |t Glossary --   |t For Further Reading 
506 0 |a restricted access  |u http://purl.org/coar/access_right/c_16ec  |f online access with authorization  |2 star 
520 |a Nuclear medicine is a growing specialized medical field in which radiopharmaceuticals, i.e. drugs associated to radioactivity, are used for diagnostic or therapeutic purposes. Since 1942, nuclear medicine has progressed in such a way that it became a major diagnostic tool in hospitals. The past ten years have seen the introduction of major technical breakthroughs which will considerably modify the landscape of cancer treatment. Once injected to the patient, the radiopharmaceutical drug aims at the tumour cell – including metastases – selectively, settles there, and emits radiation. Depending on the radiation type, the drug will either help identify the cells or destroy them. Applications are not limited to oncology; indeed, nuclear medicine has found interesting applications in cardiology and neurology as well. The new millennium saw the introduction of the Hybrid imaging technology PET/CT which combines the Positron Emission Tomography (PET) modality with conventional high quality x-ray imaging. It took another two years until PET could be combined with Magnetic Resonance Imaging (MRI) in the hybrid equipment PET/MR. New tracers (drugs for diagnosis) also came on the market with different diseases as targets, such as prostate cancer, neuroendocrine tumours, or Alzheimer’s disease. But the recent introduction of radiotherapeutics in the treatment of cancer has brought major changes on the market, for they can be much more powerful and specific than chemotherapeutics or external radiation therapy. Combining radiodiagnostics to select positive responders to a treatment with efficient radiotherapeutics opens a highway for the development of theranostics, another word for personalized medicine. This scientific book aims to introduce nuclear medicine to a larger audience, pointing out, among other things, the difficulties met by both physicians and patients when trying to access new technologies. This second edition shows how much progress has been made over the past ten years since the original book was published, and how much can be expected for patients within the next few years. 
530 |a Issued also in print. 
538 |a Mode of access: Internet via World Wide Web. 
546 |a In English. 
588 0 |a Description based on online resource; title from PDF title page (publisher's Web site, viewed 01. Dez 2022) 
650 0 |a Nuclear medicine. 
650 4 |a Medicine. 
650 4 |a Nuclear. 
650 7 |a MEDICAL / Allied Health Services / Medical Technology.  |2 bisacsh 
773 0 8 |i Title is part of eBook package:  |d De Gruyter  |t EDP Sciences Contemporary eBook-Package 2016-2020  |z 9783110756401 
773 0 8 |i Title is part of eBook package:  |d De Gruyter  |t EDP Sciences Frontlist eBook Package 2017  |z 9783111023892 
776 0 |c print  |z 9782759821402 
856 4 0 |u https://doi.org/10.1051/978-2-7598-2149-5 
856 4 0 |u https://www.degruyter.com/isbn/9782759821495 
856 4 2 |3 Cover  |u https://www.degruyter.com/document/cover/isbn/9782759821495/original 
912 |a 978-3-11-075640-1 EDP Sciences Contemporary eBook-Package 2016-2020  |c 2016  |d 2020 
912 |a 978-3-11-102389-2 EDP Sciences Frontlist eBook Package 2017  |b 2017 
912 |a EBA_BACKALL 
912 |a EBA_CL_MDPM 
912 |a EBA_EBACKALL 
912 |a EBA_EBKALL 
912 |a EBA_ECL_MDPM 
912 |a EBA_EEBKALL 
912 |a EBA_ESTMALL 
912 |a EBA_PPALL 
912 |a EBA_STMALL 
912 |a GBV-deGruyter-alles 
912 |a PDA12STME 
912 |a PDA13ENGE 
912 |a PDA18STMEE 
912 |a PDA5EBK